Mizuho Securities Reaffirm Bullish Stance on Surgery Partners (SGRY)

Surgery Partners (NASDAQ:SGRY) is one of the most promising mid-cap healthcare stocks under $50. On December 18, Mizuho Securities analyst Ann Hynes reiterated her Buy rating on Surgery Partners (NASDAQ:SGRY) stock. She has assigned a price target of $19, which leads to an upside of 21% from the current trading level. sfam_photo/Shutterstock.com Hynes’s bullish rating is backed by a positive 2026 forecast for managed care and health facilities. She highlighted that the managed care space is at the tail ...